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ABSTRACT 
 
Miranda Law: A Program and Evaluation Plan for Advancing Medication Education and 
Adherence for Diabetes and Hypertension in Umlazi Township, KwaZulu-Natal, Republic of 
South Africa 
(Under the direction of Lori Carter-Edwards) 
 
Medication adherence plays a major role in the control and management of chronic 
disease states such as diabetes and hypertension. Methods to improve medication adherence 
through medication education or increasing social support alone have not always shown to 
improve adherence rates, but have found to be contributing factors.1-3 As technology advances, 
mHealth has been increasingly explored as an avenue to combine efforts in communication, 
education, and support to patients to improve medication adherence and disease state control. 
This paper will begin with a review of the literature on mHealth programs targeted on improving 
medication education and adherence of diabetes and hypertension patients. The literature review 
was conducted on PubMed and identified seven studies for evaluation. Studies were evaluated 
for the mHealth program, implementation, and program outcomes. 
Following the literature review, this paper describes a program plan for diabetes and 
hypertension medication adherence program (INSTEP). INSTEP is a mHealth based program 
that will combines the use of medication education, improved medication communication 
strategies, and social support, to advance medication adherence and control of diabetes and 
hypertension. INSTEP will partner with the South African Department of Health, in addition to 
other key stakeholders, and launch an initial pilot program in Umlazi township primary health 
clinics. Program evaluation will be both quantitative and qualitative and both the training 
program for the primary health care clinics and patient program will be evaluation. 
Implementation evaluations and outcome evaluations will aim to provide data for quality 
improvement opportunities as the program continues to run. 
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INTRODUCTION 
Diabetes and Hypertension 
Non-communicable diseases (NCDs) have been increasing in prevalence throughout the 
world, with diabetes and hypertension being two of the most common NCDs. The World Health 
Organization (WHO) reports that from 1980 to 2014, the rate of diabetes rose from 108 million to 
422 million, with rates rising quickest in low- and middle-income countries.4 An estimated 1.1 
billion people in the world have hypertension, with nearly 2/3 living in low- and middle-income 
countries.5 As of 2015, one in four men and one in five women have hypertension.  
South Africa has been no exception to the rise of NCD’s. The H3Africa QWI-Gen study 
evaluated the prevalence and awareness of hypertension across six sites in Sub-Saharan Africa 
(Nanoro in Burkina Faso, Navrongo in Ghana, Nairobi in Kenya, Agincourt, Dikgale, and Soweto 
in South Africa) and found the highest prevalence (54.1%) in Soweto, the largest township in 
South Africa.6 The study also reports that of the three South African sites evaluated (Agincourt, 
Dikgale, and Soweto), all three had an average prevalence of hypertension greater than 40%.6 
Prevalence of hypertension has also been evaluated in Limpopo province and KwaZulu-Natal, 
reporting rates of hypertension to be 41% and 33%, respectively.7,8 Increasing rates of 
hypertension are not confined to those outside the health care workforce. A study of hypertension 
prevalence among primary health care professional nurses in the Eastern Cape reported rates of 
52%, revealing the depth and breadth of the growing problem in the country.9  
The International Diabetes Federation estimates that in 2015, nearly 2.3 million people in 
South Africa had diabetes with 500,000 – 5 million possible undiagnosed cases10 The Institute of 
Health Metrics and Evaluation reported Diabetes to be the 5th leading cause of death in South 
Africa in 2017.11 More recently published studies on the impact of lifestyle and socio-economic 
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inequalities in diabetes prevalence within the country report that 39% of diabetes is undiagnosed, 
largely due to poor access to care in areas of low socio-economic status12, which also results in 
the inability to properly determine the true rate of NCDs in these areas of the country. Socio-
economic variables are significantly associated with self-reporting of diabetes included living in 
rural areas and increasing age. Of those who self-reported diabetes in the study, there were 
findings of poor rates of treatment initiation (only 61% were being treated) and control (only 31% 
of those treated were controlled) attributed to poor diabetes education and medication 
adherence.12 Studies have also shown that among older adults (61+), diabetes is associated with 
poorer quality of life and greater disability.12 
 
Access to Quality Care 
Access to care contributes to both the under diagnoses of NCDs as well as the proper 
management of those who are diagnosed. It can be impacted by factors such as distance to the 
treatment center, the quality of care provided once patients reach the treatment center, and 
patients’ additional comorbidities. 
To address the problem of the long distances that patients have to reach primary health 
care clinics, home-based services have been implemented in areas of South Africa. The evaluation 
of an integrated community home-based care service in Limpopo Province found that the most 
common gaps in services when visiting patient homes included health education, giving 
medications, managing hypertension, and patient counseling.13 Home-based treatment groups 
were also implemented in KwaZulu-Natal, which included nurses and community health workers 
(CHW) conducting home visits, monthly follow up visits, and adherence support for the treatment 
of multi-drug resistant tuberculosis. Results of this home-based treatment group showed reduced 
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rates of needing to escalate care (referral to hospital) and a reduction of severe adverse events and 
mortality, 14 revealing promising results to expanding such care to include treatment for chronic 
diseases. 
Patients who are able to travel to primary health clinics are often faced with inadequate 
care due to high patient volume and an overworked staff. A study investigating the role of 
primary health care nurses (PHCN) that were part of a chronic illness program at primary health 
clinics in Soweto found multiple nurse complaints.15 PHCNs felt that they were given 
responsibilities to care for patients but were not given the authority to act and that they were not 
given appropriate access to patient information, and that they often felt they lacked sufficient 
knowledge and confidence and did not have physicians available to consult.15 Additionally, they 
felt the chronic disease program was not properly integrated into the clinic – resulting in staff 
shortages and inability to properly care for the patients.15 PHCNs in this program highlighted the 
need for training around chronic disease management which would improve their ability and 
confidence to support treatment and linkage to care programs across a range of diseases.15 
Interviews with PHCNs working in Umlazi, the second largest township in South Africa, reveal 
that many nurses lack the proper patient education materials to provide their patients, that they 
often do not have space to hold support groups for patients that have diabetes and hypertension, 
and they lack the knowledge to properly dose and titrate insulin, making it difficult to properly 
educate their patients on what they should be doing.16 
Although resources are often stretched in primary healthcare clinics, and nurses have 
multiple responsibilities beyond NCD screening and support, advancement is possible. A study on 
a structured NCD service in KwaZulu-Natal found that nurses, when provided with proper 
protocols and tools, are able to make an impact in advancing hypertension control for patients.17 
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This NCD program emphasized the importance of identifying and tackling adverse effects, 
educating patients on the necessity of life-long therapy, simplifying treatment regimens, and 
ensuring the patient is involved in their own care.17 Emphasizing these points, patients had 
significantly improved adherence to medications.  
Access to care can also be influenced by more pressing co-morbid disease states. For 
example, patients who are Human Immunodeficiency Virus (HIV) positive are more likely to be 
diagnosed and treated for diabetes and/or hypertension because of the urgency of their co-morbid 
disease state.18 This represents an opportunity for case finding when treating other communicable 
disease states for patients.  
 
Medication Education 
Medication education on managing diabetes and hypertension plays an important role in 
ensuring patients can adhere to their treatment regimen and thereby, successfully manage or 
control their conditions. Although both are important, medication education is distinct from health 
literacy, where the former refers to a patient’s knowledge of why and how they are doing 
something and the latter refers to a patient’s ability to read and understand instructions on taking 
medication.19  A study evaluating the knowledge of symptoms and self-management of 
hypoglycemia in patients in a diabetic clinic in KwaZulu-Natal showed that of the 200 diabetic 
patients interviewed, the majority had fair to good knowledge about hypoglycemia; however, less 
than 25%  knew what actions to take if they experienced an episode of hypoglycemia.20 This 
knowledge can be lifesaving in instances when blood sugar is dangerously low and shows the 
need to improve education provided to patients with diabetes. A study evaluating 253 patients 
from 50 primary health clinics in the Limpopo Province revealed that less than a third of patients 
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knew what hypertension was, why blood pressure (BP) was recorded, and what normal BP should 
be.21 The study also found that only 15% of the patients who received hypertension information 
received information specifically about the medications.21   
Interventions to provide medication education to patients in South Africa has been met 
with conflicting results. A group diabetes education program was launched in Cape Town, 
offering four monthly education sessions in additional to routine care, reported that over 50% of 
recruited patients did not attend a single education session.2 Additionally, the education sessions 
faced multiple barriers including the lack of space to hold session and lack of a guiding style 
(emphasis on collaboration, respect for choice and control, and empathetic listening) by the health 
promoters leading the session.2  Despite its barriers and inability to replicate positive results from 
other group education interventions, the study did show that those who attended sessions showed 
an improvement in blood pressure, and a cost-effectiveness analysis revealed $1862 per quality 
adjusted life year gained, indicating that such an intervention could be cost-effective.1,2  
In another medication education intervention, the Take Five School group education 
program was launched for individuals with type 2 diabetes in the Western Cape.3 Those who 
participated, staff and participants, felt that the groups enhanced social support and made some 
patients feel more comfortable to learn while appreciating the ability to learn from each other.3 
Constructive feedback also showed that patients would have wanted take-home materials to 
reinforce the information.3 Further evaluation of the program revealed additional areas for 
improvement including healthcare staff feeling as if their patients did not take their advice and 
patients reporting that they did not always trust the advice of healthcare staff.3 An exploration of 
patient experience in chronic care within Cape Town revealed useful information and 
opportunities for continued improvement in chronic disease care in South Africa.22 Findings of 
	 6	
the study showed that patients often face multiple barriers to effective chronic disease 
management and the majority of patients reported not receiving adequate information, counseling, 
or support from their health care providers.22 They felt the current method of care for treating 
their disease failed to meet their expectations,22 indicating a need for a more patient-centered 
approach to managing NCDs.  
 
Medication Adherence 
Patient knowledge of their chronic disease state(s) and the medication(s) they are taking is 
one link to the level of adherence for patients on NCD medications. Previously mentioned, 
several studies have reported low adherence rates among patients with chronic disease states, 
while highlighting the importance of understanding and accepting the medications prescribed.13,17 
A cross-sectional study in Limpopo province evaluated 137 patients with diabetes and found that 
younger age, current employment, and the ability to keep appointments were factors associated 
with improved medication adherence.23 Poor adherence was often reported to be due to not having 
their pills, forgetting to take their medication, and travelling without taking enough pills with 
them to last their entire trip.23 Those patients that were adherent to their medications 
recommended setting reminders, taking medications at meal times, and utilizing a treatment 
supporter.23 
Methods have been utilized in an attempt to improve medication adherence for patients, 
some of which include next-generation electronic pill-boxes, adherence clubs, and medication 
pick-up points.  The next-generation pillbox was tested for drug resistant tuberculosis and was 
found to be accepted and helpful for patients to remember to take their medications.24 Patients 
who tested the electronic pill box made recommendations for the pill box to be able to set alarms 
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and reported that knowing someone was monitoring whether or not they were taking their 
medications made them feel special.24 In an interview with a patient at a primary health care clinic 
in KwaZulu-Natal, the patient discussed a medication e-diary that was provided to him by a 
private physician which provides reminders for him to take his medication.25 He reports that he 
always remembers his medications because an alarm goes off at 6:00 PM/18:00 and he has to 
answer a series of questions.25 
Adherence clubs, which are medication pick up sites located closer to patient homes and 
are led by nurses, are another way to help patients become more adherent to their medications. A 
study on utilizing adherence clubs to improve antiretroviral therapy showed to be acceptable 
among patients, adoptable, appropriate and feasible.26 Unfortunately, interviews with nurses in 
primary health care clinics in KwaZulu-Natal revealed multiple barriers with adherence clubs.16 
Due to the fact that nurses are tasked with transporting medications to adherence club locations, 
nurses often reported that transportation was lacking and therefore medications were rarely 
delivered to the areas that patients wanted to pick them up.16 Nurses did report, however, that 
when transportation was available, the adherence clubs did work well to provide patients with 
medications closer to where they lived.16 
The South African National Department of Health presented the Central Chronic 
Medication Dispensing and Distribution (CCMDD) model in 2014.27 CCMDD provides   
medications for chronic disease states across many locations in South Africa, called pick up 
points.. Although these pick-up points work well for those patients who are enrolled, nurses at the 
primary healthcare clinics report that they would like more education on CCMDD because they 
do not understand how it really works.16 Without nurses actively promoting patient enrollment 
into the CCMDD program, its impact and ability to improve medication adherence is limited.  
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MHealth 
South Africa is home to more than 76 million mobile phone subscribers, with an average 
of 156 mobile cellular telephone subscriptions per 100 people.28 Mobile technology provides an 
avenue to develop innovative solutions for delivering healthcare to patients. The role of mobile 
health, also known as mHealth, has been studied in a variety of settings, including its role in care 
for patients with chronic disease states. MHealth has been found to be a promising tool for 
addressing access to care, coverage, and equity gaps in developing countries and low-resource 
settings.29 It has been identified for use in aiding emergency response systems, disease 
surveillance, patient monitoring, health services reporting, and training and continuing 
professional development.28  
Overall, mHealth has shown positive impact on chronic disease management in low and 
middle income countries (LMIC).29 Within South Africa, however, previous systematic reviews 
of mHealth programs found insufficient evidence to prove the impact of mHealth on health 
outcomes.30 Additional studies, beyond donor funded pilot programs launched in small regions of 
the country, are needed to determine the true impact of mHealth on the health care delivery 
process in South Africa. South Africa’s mHealth strategy calls for strategies to explore change 
management, the return on investment/cost-benefit, and further evidence of success.28  
 
Program Rationale 
As rates of diabetes and hypertension in South Africa continue to grow, methods to 
improve access to care, medication education, and medication adherence must be explored. 
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Current literature and interviews with PHCNs and patients provides much needed insight into 
methods, barriers, and opportunities for advancement. 
The goal of the proposed program is to develop an effective, acceptable, resource-
efficient, mobile application (app) method of improving medication education and adherence for 
patients, and when needed, for PHCNs. PHCN interviews report that regardless of whether 
patients have what they need for their health, they almost always have a cellular device.16 The 
development of a mobile app that can meet the health care needs of South African patients with 
diabetes and hypertension may be useful in improving the care of these patients. Mobile 
applications can be inexpensive, implemented with minimal additional resources, and can be 
updated with new information when necessary. Vital to its success is the method in which it is 
incorporated into the workflow of PHCNs at the primary healthcare clinics and the lives of the 
patients that use it. 
This paper will begin with a systematic review of current mobile applications aimed at 
improving medication education and or medication adherence and will highlight their outcomes 
within Sub-Saharan Africa. It will move into a program plan for the development and 
implementation of the mobile technology and its place in medication education and medication 
adherence. An evaluation plan for both the application and the implementation of its use in care 
will be presented and the paper will conclude with a discussion of the possible implications of the 
pilot project and its potential for scalability if successful. 
 
SYSTEMATIC REVIEW  
 MomConnect, launched in 2014 was the first large scale mHealth initiative provided by 
the South African Department of Health (DOH).31 By 2017 the program had over 350,000 users 
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and has since reached over 1.5 million pregnant women.31,32 The mHealth initiative allowed 
expecting mothers to subscribe to a messaging service that provided information and 
encouragement to register their pregnancy at the Ante Natal Clinic.32 Shortly following the 
MomConnect mHealth program, the South African Government published a mHealth strategy in 
2015 with a mission to utilize mHealth as an integral part of health care delivery and improve the 
health system in South Africa.28 The aim of the strategy was to develop a single harmonized and 
comprehensive plan utilizing mHealth to support health sector priorities and meet the health 
needs of individuals, health care providers, managers, and policy makers.28 Despite these aims, 
there has not be a large scale mHealth program implemented in South Africa and true 
understanding of how to target rising NCDs such as diabetes and hypertension through mHealth 
is still unknown. 
 With growing interest in the use and streamlining of mHealth interventions and the aims 
of South African mHealth strategy, the following research question was selected, “What mHealth 
interventions targeting diabetes and hypertension education and/or medication adherence have 
been utilized and accepted in Sub-Saharan Africa and what outcomes have they produced?”  
Search Strategy 
 A search strategy using PubMed was implemented to identify and critique current 
literature on the use of mHealth interventions in Sub-Saharan Africa target hypertension and type 
2 diabetes management. Search terms included diabetes, hypertension, Africa, mobile, mHealth, 
medication, adherence, and medication education. PubMed search results were exported and 
imported into CovidenceTM, software that is used for systematic reviews, with duplicate articles 
automatically removed. An abstract review was conducted, followed by a full-text review, and 
articles were included or excluded based on pre-specified inclusion and exclusion criteria (Table 
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1). Final full-text articles that were selected for inclusion were evaluated for intervention, 
methods, and outcomes/impact. Collectively, articles were assessed for limitations in the 
literature and gaps in knowledge. 
 
Table 1: Systematic Review Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
English Language English language not available 
Located in Sub-Saharan Africa Located elsewhere or includes too many 
geographic areas 
Intervention involves the use of mobile 
technology 
Intervention is not mobile technology related 
or includes use of additional technologies and 
methods  
Intervention focused on diabetes and 
hypertension management 
Intervention focused on diagnoses, case 
detection, or is not focused on NCDs 
Intervention does not require significant 
additional human resources 
Intervention requires significant additional 
time from healthcare staff or additional staff 
to be hired 
Intervention must report outcomes Literature that publishes only protocols 
without outcomes 
 
Results 
Review Process 
 A total of 115 studies were identified with 42 duplicates removed. Seventy-three studies 
were screened by abstract and 24 full-text studies were assessed for eligibility, with 7 studies 
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being included in the final review (Figure 1). During abstract review, a number of studies 
appeared to qualify, but on full-text review, were excluded based on a participant population 
outside of Sub-Saharan Africa or an intervention that was not centered around implementation of 
an mHealth intervention. MHealth interventions that included a mix of participants from 
different geographic regions, including Sub-Saharan African, were excluded due to increased 
heterogeneity of results and reduced external applicability of outcomes. Two articles were 
excluded due to only publishing the intervention protocol and lacking any intervention outcomes 
and two additional articles reported outcome results on the implementation of the mHealth 
intervention without any outcomes on health care, and were therefore also excluded. Additional 
reasons for exclusion after full text review can be found in figure 1. A total of 7 articles were 
included in the final systematic review and a brief summary of each can be found in Table 2.  
 
Study Characteristics 
 Of the seven included articles, three were reports regarding the same mHealth 
intervention describing process outcomes, quantitative program outcomes, and qualitative 
program outcomes. The remaining four articles described unique mHealth interventions. 
The intervention setting of included articles were relatively homogenous. One 
intervention occurred in Ghana, and six were conducted in South Africa. Of the six articles 
focused on South Africa, four of the six articles described interventions that occurred in Cape 
Town, one study was in Mpumalanga province, and one was unspecified.  
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Figure 1: PRISMA Diagram generated by CovidenceTM. 
 
The majority of mHealth interventions focused on short message service (SMS) text 
messaging interventions and evaluated the impact of those messages on controlling chronic 
disease states. One intervention provided advance Bluetooth monitoring technology paired to a 
provided mobile phone. One study evaluated “bottom up” phone interventions which was 
defined as informal ways that patients and health care staff were utilizing their mobile phones for 
health care. Additionally, one study, in addition to SMS test messaging, utilized a buddy system 
as peer support for improved health.  
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Study participant demographics were variable across studies. Smaller studies included 
20-30 participants whereas larger studies included as many as 1372 participants. Studies which 
fell in between had enrolled 60, 156, and 223 participants. The majority of studies included both 
men and women participants, with only one study concentrating on women participants only. 
One study that chose to conduct focus groups with stakeholders regarding the mHealth 
intervention included primary health care professionals (physicians, nurses, pharmacists, allied 
health professionals, and reception staff) as well as third party providers of off-site pre-packaged 
prescriptions and health care system service providers. Another study that evaluated the “bottom-
up” approach interviewed patients and health care workers.  
All studies focused on improving care for chronic diseases. Five studies focused on 
improving hypertension medication adherence, one study focused on improving diabetes 
management for women, and one study focused on “chronic diseases” in addition to pregnant 
women.  
 
Table 2: Review Summary of Included Articles 
Author Population Intervention Methods Results 
Anstay 
Watkins, J33  
Patients with 
chronic 
disease, 
nurses, and 
physicians in 
Mpumalanga 
province, 
South Africa 
Determination of 
how mobile phones 
are currently being 
used from the 
“bottom-up” by 
patients and health 
workers 
Interview study to 
examine the 
current use of 
health-related 
digital mobile 
communication 
among patients 
and health 
workers 
40% of patients,  
60% of nurses, and 
all doctors reported 
using their mobile 
phones more than 
once per week for 
health-related 
purposes. Over half 
of the patients used 
their mobile phones 
to help set reminders 
and alarms to 
manage their own 
chronic disease.  
Bobrow, K34 General adult 
population 
attending 
Parallel, three 
group (1:1:1) 
Personalized 
SMS text-
messages, 
SBP decreased from 
baseline to 12 
months for all 
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Author Population Intervention Methods Results 
outpatient 
chronic 
disease 
services in a 
single public 
clinic in Cape 
Town, South 
Africa. 
randomized 
controlled trial  
interactive 
message group 
messages 
groups. The mean 
adjusted difference 
in change for the 
information-only 
groups compared to 
usual care was -2.2 
mm Hg (p = 0.046 
and for the 
interactive message 
group compared to 
usual care -1.6 mm 
Hg (p = 0.16) 
Bobrow, K35 South African 
health care 
workers and 
patients with 
high blood 
pressure or 
NCDs 
Theory-based 
behavior 
intervention to 
support adherence 
to high blood 
pressure treatment 
delivered by mobile 
phone text message 
Utilization of the 
Medical Research 
Council 
Framework for 
the development 
of complex 
interventions to 
create a mobile 
application that 
provides 
reminders for 
clinical 
appointments, 
medication 
adherence, health 
information, and 
how to navigate 
the health care 
system. 
The MRC 
framework is useful 
for developing 
mobile health 
interventions in low 
resource settings. 
Treatment adherence 
can be supported by 
well-regarded 
messages that are 
polite, credible, 
contextualized, and 
endorsed by a 
member of the 
primary health care 
facility staff. 
Hacking, D36 223 
hypertension 
clinic patients 
in Cape 
Town, South 
Africa 
90 mobile text 
messages over 17 
weeks 
Participants were 
randomly 
assigned to 
intervention or 
control groups. 
Baseline 
questionnaires 
were given to 
both groups to 
gauge health 
knowledge, the 
intervention 
No statistically 
significant changes 
in health were 
observed between 
groups. The 
intervention group 
reported increase in 
behavior changes.  
	 16	
Author Population Intervention Methods Results 
Leon, N37 General Adult 
Population 
attending the 
outpatient 
chronic 
disease 
services in a 
single large 
public sector 
clinic in Cape 
Town, South 
Africa 
12-month 
adherence support 
intervention 
delivered via SMS-
text message (in 
local language) on 
blood pressure and 
treatment adherence 
compared 
Three-armed 
(usual care, one-
directional SMS, 
interactive SMS) 
randomized 
controlled trial, 
combination of 
convenience and 
purposive 
sampling. Focus 
groups and 
individual 
interviews 
explored 
perceptions and 
experiences of 
participants 
Most participants 
had a positive 
experience with the 
SMS-text 
intervention, 
however, not all 
reported that it 
helped improve 
adherence behavior. 
1/3 reported the 
intervention highly 
beneficial resulting 
in improved attitude, 
development of a 
sustainable routine, 
improved health 
condition, and 
improved adherence 
behavior 
Rotheram-
Borus, M.J38 
Women with 
Diabetes in 
Cape Town, 
South Africa 
12-week program 
linking women with 
a buddy via a 
mobile phone for 
support. SMS 
messaging about 
health behavior 
3-component 
intervention, 
series of 12- 
psycho-
educational group 
session, mobile 
phone probes that 
asked about 
health daily, text 
messaging to a 
buddy to support 
lifestyle changes. 
Weekly sessions 
with participants 
22 participants. 
Hours slept each 
night increased 
between baseline 
and three months. 
No other statistically 
significant changes.  
Sarfo, F39 Stroke 
survivors at a 
single tertiary 
medical 
system in 
Ghana 
2-arm cluster pilot 
randomized 
controlled trial.  
Subjects received 
a blue-toothed 
UA-767Plus BT 
BP device and 
smart phone for 
monitoring and 
reporting BP 
measurements 
and medications 
intake for 3 
months compared 
with standard care 
Systolic BP <140 
mmHg at month 3 
was found in 20/30 
subjects in the 
intervention arm vs 
14/30 in the control 
arm (p=0.12) 
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Study Outcomes 
 Study outcomes were mixed in showing effectiveness of mHealth interventions on 
improving control of chronic disease states and described both qualitative and quantitative 
outcomes. 
Three related articles described the process outcomes for developing a mHealth SMS text 
messaging intervention,35 qualitative feedback from its participants,37 and quantitative outcomes 
on improving blood pressure control using the mHealth intervention.34 In developing an mHealth 
SMS text messaging intervention, semi-structured interviews and focus groups with different 
stakeholders revealed the importance of developing messages that were polite in tone, contained 
credible information, was context based, and was endorsed by a known member of the primary 
care staff.35 Participants more highly valued SMS text messages that included a named provider 
at their clinic and would be more likely to respond to such a message.35 Participants also reported 
they valued being able to select the time of day that messages were sent so as not to disturb other 
commitments and being sent a follow SMS text message if a scheduled appointment was 
missed.35 The feedback collected during the development process was utilized to created the 
mHealth application. 
Quantitative and qualitative outcomes were evaluated using the above mentioned 
mHealth application. To evaluate quantitative outcomes related to management of blood pressure 
using the mHealth intervention, participants were randomized in a 1:1:1 fashion into one of three 
groups, usual care, information only SMS, or interactive SMS and the primary outcome was 
change in systolic blood pressure at 12-months from baseline.34 At 12 months, participants in the 
information only SMS leg had average systolic blood pressure (SBP) 2.2 mm Hg lower than the 
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usual care leg, and participants in the interactive SMS leg had average SBP 1.6 mm Hg less than 
the usual care leg.34 Neither of these results were of statistical significance.34 To evaluate 
qualitative outcomes, two focus groups and 15 individual interviews were conducted.37 The 
majority of participants reported they were comfortable with the SMS text messaging 
technology. Those that benefitted the most from the intervention had previously been struggling 
with adherence due to high personal stress and the intervention was able to provide the practical 
and emotional support needed to help them improve their behavior.37 
Other studies also focused on improving hypertension care. A mixed-methods study 
enrolled 223 hypertension clinic patients to receive either SMS text messages with hypertension 
health information or usual care.36  All participants were administered a baseline knowledge 
questionnaire at the beginning and end of the 17 weeks mHealth intervention and no between 
group differences were noted in overall health knowledge.36 Sarfo et al conducted a 2-arm cluster 
pilot randomized controlled trial for 60 recent stroke survivors with the intervention arm 
receiving a blue-toothed UA-767Plus BT BP device and smart phone for monitoring and 
reporting BP measurements and the control arm receiving usual care. Based on reported 
medication adherence (evaluated by medication possession at month three) the smart phone app 
sent tailored motivational text messages to participants.39 After three months, they found that 
66.7% of subjected in the intervention arm achieved SBP < 140 mm Hg compared with 46.7% of 
patients in the usual care arm (p=0.03).39 Adherence to medications was also reported to be 10% 
higher in the intervention arm.39 
One study focused on improving diabetes care among women. Twenty-two women with 
diabetes from Cape Town were enrolled in a 3-month program focused on improving health 
knowledge to better manage diabetes through text messages.38 The program included 3 
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components, 12 psycho-educational group sessions, mobile phone probes that asked about daily 
health, and text messaging to a randomly assigned buddy to support lifestyle changes.38 Results 
evaluated diabetes specific measures such as body mass index, blood pressure, emotional 
distress, coping styles, and blood sugar were evaluated.38 The intervention did not show 
improvements in body mass index, blood pressure, or blood glucose, however, participants did 
report higher levels of social support, positive actions, and reduced depression withdrawal.38 
Lastly, Anstey-Watkins and colleagues (2018) evaluated current mHealth interventions 
that were informally occurring in the health care setting when caring for patients with chronic 
disease (including hypertension and diabetes) and pregnant women.33 They interviewed 113 
patients and 43 health workers in Mpumalanga province and found that 40% of the patients and 
60% of the nurses reported using their mobile phones more than once per week for health-related 
purposes.33 Health workers most commonly used their phones to gather health information and 
patients most commonly used their phones to support management of their chronic disease.33 
Despite the high use of “bottom up” mHealth, many health care staff interviewed expressed 
frustration and discontent at having to pay for their own airtime to use their mobile phone for 
work purposes and patients often expressed that they simply do not have the money to buy 
airtime.33  
 
Discussion 
 A review of current mHealth interventions and their outcomes provide valuable insight 
into the development of future mHealth related activities. Although there were minimal studies 
that could be evaluated, insight into the “bottom-up” use of mHealth/mobile phones informs 
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program planners that the use of mobile phones to improve health is already occurring and is 
accepted by both health care workers and patients.  
The use of mHealth to improve control of hypertension could be promising as 
interventions both low cost and high cost seem to have shown improvements in SBP in just a few 
months. Alternatively, mHealth interventions using SMS text messaging solely targeted at 
improving health knowledge seemed to be ineffective in educating patients about their chronic 
disease. Utilizing mHealth SMS text messaging to provide social support for improving health 
seemed to be effective and could be further explored as an opportunity to improve medication 
adherence. 
A review of the current literature also identifies a number of gaps in knowledge 
surrounding mHealth. Important to note is that a number of these interventions were pilot 
programs and had a small number of participants. It is unknown whether these programs would 
produce similar results if scaled up or if scale up is even possible, feasible, and/or sustainable. 
Additionally, none of the current reports of mHealth interventions for chronic disease 
management indicated any cost-effectiveness outcomes and therefore, it is unknown whether or 
not these programs are worth the investment of already limited resources. Lastly, these pilot 
mHealth programs were all developed and created independent of any involvement from the 
South African Department of Health, leaving a gap in knowledge on how the department of 
health could influence or advance such programs to reach their ultimate mHealth goals. 
Partnership and collaboration with the South African Government is a crucial step in ensuring 
mHealth programs can be sustainable in the long term so, based on currently literature, it is hard 
to determine whether or not these programs could be 1) scalable and 2) sustainable.  
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PROGRAM PLAN 
Program Overview 
 The National Health Act of 2003 required the South African Department of Health to 
develop a framework and structure for a uniform health system.40  Since then, the DOH has 
launched programs such as CCMDD and MomConnect to address access to care for patients in 
even the most rural areas.27,32,41 Despite these efforts, an evaluation of the South African health 
care system still reveals several issues about public institutions including insufficient health care 
workers, highly preventable adverse events, and poor-quality of healthcare delivery.42 Increasing 
disease burden due to rising rates of NCDs further strains the insufficient health care workforce. 
The South African mHealth strategy aims to utilize mHealth as an integral part of health 
care delivery in the country.28 South African has over 76 million mobile phone subscribers and 
an average of 146 mobile cellular telephone subscriptions per 100 persons.28 Among low-income 
populations, 75% of mobile phone owners are 15 years or older.28 MHealth can be used to 
remotely monitor patients and serve as an extension of health care services, health promotion, 
health services reporting.28  
 Although supported by the government, there are still a number of barriers that prevent 
fully incorporating mHealth into the health care routine of the country. Major challenges have 
included, but are not limited to, the lack of alignment and integration of interventions into health 
plans, strategies, and systems, an absence of government leadership and coordination, poor 
documentation and learning of best mHealth practices, and an absence of practical approaches to 
privacy and security.  
 The diabetes and hypertension medication adherence program (INSTEP) is a mHealth 
based program that will target medication adherence and social support for patients with 
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hypertension and diabetes. INSTEP will be incorporated into the workflow of primary health 
care clinics and serve to augment patient care around diabetes and hypertension management. 
Patients with diabetes and hypertension will be educated by nurses about the program and use of 
care through their mobile device and if they agree to participate in the program, initial health 
information will be asked and electronically recorded by the nurse. INSTEP will utilize 
Unstructured Supplementary Service Data (USSD) technology and the computer framework 
generating and receiving the information will serve as a secure interactive platform for 
communication to remind patients to take medications, inform patients about appointments, send 
informational messages, and connect patients with others nearby for social support. With the use 
of USSD technology, INSTEP will not be limited to patients with phones that can connect to the 
internet, or require patients to purchase airtime. 
INSTEP’s initial target population will be patients with diabetes and hypertension in 
Umlazi township. INSTEP will partner with the South African Department of Health to develop 
1) agreed upon process and outcome measures that are of importance to both the program team 
and the Department of Health, 2) agreed upon cost-effectiveness evaluations and 3) a projected 
sustainable funding model, and in this way, will work towards addressing major gaps in mHealth 
knowledge and implementation. At least 50% of INSTEP’s 12-member program team will be 
local public health professionals, nurses, physicians, pharmacists, and patients. INSTEP hopes to 
make a long-term impact in the health of its users by providing a low resource solution to 
improving management and control of diabetes and hypertension, thereby preventing morbidity 
and mortality from disease complications. 
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Program Context 
Political Environment and Consistency with National Priorities 
 South Africa held its first democratic election in 1994, electing President Nelson 
Mandela, and was subsequently divided into its nine provinces (replacing the previously existing 
four provinces and ten black homelands).43 Challenged with poverty, unemployment, and 
inequality, in 2011, the government developed the National Development Plan: Vision for 2030 
(NDP).43 The NDP recognized the deficient workforce, poor infrastructure, and poor quality of 
public services and set an approach to change that would improve opportunities, increase 
employment, and reduce poverty. The NDP stated the need for South Africa’s rural community 
to have better opportunities to participate fully in the economic, social, and political life of the 
country.44 
 The NDP, currently still underway, is comprehensive and addresses advancement in 
multiple areas, including, but not limited to, reducing greenhouse gas emission to prevent climate 
change, using science and technology to revolutionize services, establishing effective and 
affordable transportation, and making high-speed broadband internet universally available at 
competitive prices.44 Critical actions mentioned within NDP related to health care include 
phasing in national health insurance with a focus on advancing public facilities, increasing the 
health care workforce, and reducing the relative cost of private health care.44  
 Mhealth utilizes widely available technology that works alongside goals and critical 
actions set forth in the NDP.  INSTEP is well aligned with national priorities focused on health 
care and compliments its emphasis on advancing technological innovations that can aid in 
providing better services to South Africans.  
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Acceptability to Providers and Recipients 
 As previously mentioned, South Africa is home to more than 76 million mobile phone 
subscribers.28 In a study evaluating patient use of mobile devices, all 113 interviewed patients 
owned their own mobile phone, of which half of the phones had internet connection 
capabilities.33 Qualitative studies evaluating the acceptability of SMS text-messaging as a 
method to improve patient care and outcomes reported findings that patients as well as health 
care workers felt that use of mobile phones as a way to follow up were acceptable, and in many 
instances, were already being used in this manner even without a formal program.33,35,37 
Providers even reported that they were comfortable with SMS text-messages including their 
name as long as the messages were in compliance with the Department of Health guidelines.35  
To ensure nursing staff and physicians are open to participating INSTEP and are clear on what 
the program will require and how it will be run, both informational and training sessions will be 
held at each primary healthcare center.   
  
Financial Resources 
 INSTEP will be in line with many of the strategic initiatives of the South African 
Government. A partnership with the South African Department of Health will explore 
opportunities for government funding to be a sustainable financial contributor to the program, 
ensuring that process and outcomes monitoring for cost-effectiveness is in place and is projected 
to show an overall cost-savings once the program is successfully integrated into public health 
care. 
 MHealth grants are increasingly available from a number of different institutions. The US 
National Institutes of Health offers mHealth grants for individuals with chronic conditions to 
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promote effective patient-provider communication, adherence to treatment and self-management 
($125,00 per year for R21, $200,000 per year for R33) that require partnerships between at least 
one institution from the United States and one from a LMIC institution.45 Such partnerships are 
certainly possible and are already planned for within INSTEP. Importantly, application to this 
grant is feasible within the current time frame (letter of intent due August 24, 2020, application 
due date September 24, 2020) making it a possible funding mechanism for the INSTEP program 
over a longer period of time. 
   
Technical Feasibility 
 The prevalence of mobile phones among the South African population make it 
technically feasible to utilize mHealth as a solution to delivering health care support and 
information between health care providers and patients. The largest barrier to overcome is the 
limited ability for many patients to afford airtime and connect to the internet. Additional points 
to consider in developing an mHealth based intervention and pairing it with the concept of 
producing a mobile application is the fact that although mobile phones are highly prevalent, not 
all phones have the capability to connect to the internet, and therefore, could not download a new 
application even if the patient could afford it.  
 USSD is a method of communication highly utilized within Africa. Despite a mere 18% 
penetration of internet connectivity on the continent, there is still nearly 80% penetration of 
mobile phones, many of which has users that rely heavily on USSD use within phones that may 
not have the processing power of android and iOS devices used in developed nations.46 USSD 
allows the user to dial a USSD code in their phone which connects their phone to a mobile 
network. The mobile operator then uses its computers to connect to the internet (Figure 2). 
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MomConnect utilized USSD to enroll pregnant women into the national pregnancy register. 
INSTEP would utilize USSD to communicate with patients regarding adherence of medications 
and social opportunities.  
Figure 2: Modern USSD Workflow46 
 
 
Engagement of Key Stakeholders 
 Stakeholder buy-in and program acceptability to nurses and patients will be crucial to the 
success of INSTEP. Partnering with the Department of Health and gaining their support will be 
vital in successfully reaching long-term goals and scaling up of the program. Additional 
stakeholders include, local non-profit non-governmental organizations, the physicians, and the 
nurses within the primary health care facilities. In a setting where staff is already insufficient, 
launching new programs that require additional training and possibly additional time is often not 
appealing to health care staff. Ensuring that the implementation of INSTEP is in line with the 
priorities of health care staff in the primary health care clinics is a necessity. Appropriate training 
and resources must be provided to the entire clinic staff to ensure the program is clearly 
understood and can be incorporated seamlessly into the daily workflow of the staff. Patients are 
another stakeholder group, and often one of the most important ones. Their understanding, 
acceptability, and willingness to participate in INSTEP will be the only way that the program can 
be impactful. Lastly, in an effort to ensure INSTEP is well aligned with the NDP, another 
stakeholder that will be brought to the table for open discussion when developing and launching 
INSTEP include individuals from the South African Government. 
Dial	USSD	
Code
Phone	
connects	to	
the	mobile	
network
The	Mobile	
operator's	
computers	
connect	to	the	
internet
The	internet	
connects	the	
mobile	
operator's	
computers	to	
another	
developer's	
computers
The	
developer's	
computer	
sends	back	a	
response	over	
the	internet
The	internet	
carries	that	
response	back	
to	the	mobile	
operator's	
computers
The	mobile	
opeartor	takes	
the	response	
and	sends	it	
back	over	the	
network
The	mobile	
networks	
connects	to	
your	phone	to	
send	you	the	
message
	 27	
 
Program Theory 
 It has been shown that health programs, including mHealth programs, are most successful 
when developed alongside a set of health behavior theories. INSTEP’s development and 
implementation will be rooted in concepts from the Health Belief Model (HBM), the Social 
Cognitive Theory (SCT), and the Social Network Theory (SNT) 
HBM was initially developed in the 1950’s to help with identification of why people do 
or don’t utilize preventive services offered by public health departments.47 HBM focuses on six 
constructs of individual behavior, risk susceptibility, risk severity, benefits to action, barriers to 
action, and cues to action.47,48 INSTEP will work towards addressing each of the six HBM areas 
at different points within the program. Due to the fact that chronic disease states such as diabetes 
and hypertension can be non-symptomatic for a number of years, patients may believe that they 
will be ok and that the disease may not impact them too much. To address individual perceptions 
of risk susceptibility and risk severity, after initial enrollment, participants, through their mobile 
device, will be asked questions about perceived risk of susceptibility to complications from 
diabetes or hypertension and their perceived severity of those complications. Additionally, 
patients will be asked about their perceived self-efficacy in being able to take action to prevent 
complications from their disease. This information will be stored and utilized to send occasional 
relevant informational messages to the patient alongside their medication reminders. 
To address modifying factors of barriers and cues to action, INSTEP will send adherence 
messages to patients based on their current medication regimens. Lastly, to ensure patients 
understand the value of medication adherence, messages regarding benefits of adherence will be 
sent to patients throughout the month, and especially when adherence is reported to be high. 
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SCT is an interpersonal model of health behavior and is built on the theory that the 
interaction between behavior, personal cognitive factors, and socioenvironmental influences 
shapes a person’s actions, a term called reciprocal determinism. Major constructs within this 
model include personal cognitive factors (an individual’s ability to self-regulate behavior), 
Socioenvironmental factors (an individual’s perceived physical environment), and behavioral 
factors (an individual’s actions that are either health-enhancing or health-compromising).47,49 
INSTEP’s main focus within this model will be on the socioenvironmental factors and 
supporting behavioral factors. INSTEP will focus on social support within the 
socioenvironmental construct and provide opportunities for patients to engage with other patients 
in their nearby area that have the same disease state. Patients will be given opportunities to 
message each other, and if they wish, to meet with each other on a voluntary basis to provide 
support for each other as they work towards improving their health. Social support through 
INSTEP will be aimed at providing emotional support, information support, and esteem 
support.49 Social support can aid adherence to new behaviors but also improve perceived self-
efficacy. To support behavioral factors associated with medication adherence, patients who 
utilize INSTEP and report at least 85% medication adherence to their medicines each month will 
be provided with transportation money to their primary health clinic to receive a refill of their 
medications, when needed. This will be a positive reinforcement reward for improving behavior 
in taking their medications.  
SNT, for purposes of INSTEP, is described as the influence of the relationships among 
people. SNT posits that network environmental influences are powerful determinants of 
behavior. Along these lines, INSTEP will intentionally work towards developing social networks 
through social support that can promote medication adherence behaviors. Ideally, data on 
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medication adherence rates can be utilized to provide social support in a 2:1 ratio, two patients 
that have relatively high rates of medication adherence with one patient that has a lower rate of 
adherence.  
These three health behavior models target both individual and interpersonal behaviors. 
INSTEP will strategically utilize each of these theories to develop participant’s personal beliefs 
in self-efficacy, improved self-motivation to improve their health and prevent disease 
complications through medication adherence, and reduce barriers to medication adherence 
through education and reminders.  
 
Goals and Objectives 
The overall goal of the diabetes and hypertension medication adherence program 
(INSTEP) is to reduce complications from diabetes and hypertension by improving medication 
therapy adherence for patients in Umlazi township through use of mHealth as a readily available 
communication, adherence, and education resource.  
 
Short Term Goals and Activities	(for further details, please see Figure 3 and Figure 4.)	
1. By month 3 establish a working partnership with a local non-governmental organization 
and the Department of Health. 
• Activities: INSTEP program director to conduct stakeholder meeting first with a 
local prominent non-governmental organization and then with the Department of 
Health to establish partnerships with Howard University College of Pharmacy. 
INSTEP program concept will be presented with opportunity for feedback. 
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Interests from the Department of Health (cost-effectiveness evaluations, 
sustainability and scalability evaluations, etc) will be built into the program. 
2. By month 5, secure necessary funding for development and management of mHealth 
messaging technology and platform. 
• Activities: INSTEP program director to secure funding through agreements with 
the Department of Health to supplement transportation costs for participants who 
are 85% (take medications 26/30 days) adherence to their medications. INSTEP 
program director to apply for NIH funding grants. 
3. By month 6, establish INSTEP’s 12-member program team, including six local members 
from Umlazi. 
• Activities: INSTEP program director will visit Umlazi Primary health clinics and 
recruit two nurses, one physician, one pharmacist, and two patients, to be a part of 
the program team. INSTEP program director will also hire one local program 
manager, one local information technology specialists, one program developer, 
one local administrative assistant, one pharmaco-economics research specialist 
(from any location), and one public health specialist (from any location).  
4. By month 6, establish a working relationship with the Primary Health Clinics in Umlazi 
Township. 
• Activities: INSTEP’s six program team members (nurses, physician, pharmacist, 
patients) will visit Umlazi’s tertiary care hospital (Prince Mshiyeni) and each 
primary health clinic. The team will meet with the hospital/clinic directors as well 
as health care staff to explain the program, how the program can benefit the 
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hospital/clinic, and the minimal resources it will require from each clinic to be a 
part of INSTEP. 
5. By month 8, develop mHealth messaging platform and have it ready for use. 
• Activities: INSTEP’s program manager, information technology specialist, 
program developer, and administrative assistant, will purchase necessary 
hardware and software to develop USSD platform. Program developer will work 
towards building messaging logic to account for messages that must be sent to 
participants for adherence, social support, and education. Program developer will 
develop a secure data platform to record patient responses to messages to track 
adherence and attendance at clinic appointments. 
6. By month 12 conduct INSTEP trainings for all nurses and physicians in each of the 
Primary Health Clinics in Umlazi Township. 
• Activities: INSTEP’s six program team members (nurses, physician, pharmacist, 
patients) will visit hospitals and primary health clinics in Umlazi that agreed to 
run the INSTEP program and conduct onsite trainings. 
7. By month 13, ensure all primary health clinics in Umlazi are actively recruiting and 
participating in the INSTEP program. 
• Activities: After each training, INSTEP’s seven program team members (nurses, 
physician, pharmacist, patients, public health specialist) will visit hospitals and 
primary health clinics in Umlazi that agreed to run the INSTEP program and 
conduct focus groups with the nurses and physicians to determine how the 
program is running and identify any barriers or opportunities to provide clarity on 
the program. Public Health specialist will evaluate present state of program and 
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determine if any adjustments/quality improvement changes need to be made 
before proceeding. 
8. By month 22, enroll at least 200 participants into the INSTEP program 
• Activities: Information Technology specialist and program manager will track 
enrollment statistics at 10, 13, 16, and 17 months. If enrollment is low, visits to 
primary health clinics will be made to determine current barriers to enrollment. 
9. By month 24, increase self-efficacy and medication adherence of participants who have 
been enrolled in the program for at least 6 months by 15%  
• Activities: Baseline survey will be administered via USSD messages upon 
enrollment to establish participant self-perceived efficacy. Survey will be re-
administered 6 months after enrollment into the program. Interactive USSD 
messages will track medication adherence rates. 
10. By month 24, have at least 50% of program participants meeting with a social support 
network of other patients with the same disease state 
• Activities: Train nurses to emphasize the value of meeting with others that have 
similar disease states so that you can help and support each other. Utilize 
messages to help organize social opportunities for participants. 
 
Long Term Goals 
1. By month 36, at least 50% of all patients being seen at primary health clinics in Umlazi 
for diabetes or hypertension will be enrolled in INSTEP. 
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• Activities: Enrollment feedback will be elicited from primary health clinics every 
6 months to identify opportunities to increase enrollment and to help resolve any 
barriers that may be present. 
2. By year 4, reduce A1c levels of at least 30% of INSTEP participants with diabetes by 3% 
or reach target goal of <7%. 
• Activities: A1c levels will be measured at least once every 6-12 months for 3 
years, for all INSTEP participants with diabetes. This will be provided free of cost 
to participants using A1c Point of Care machines provided through the INSTEP 
program.  
3. By year 4, reduce blood pressure of at least 30% of INSTEP participants with 
hypertension by 20/10 mmHg or reach target goal of <130/80 mm Hg for 3 or more 
months. 
• Activities: Blood pressure will be measured at every monthly visit to the clinic. 
Automatic blood pressure machines (two per clinic) will be provided to chronic 
disease nurses in each primary health clinic. Training will be provided on how 
they are used. 
4. By year 5, Complete cost-benefit evaluations to determine cost-savings of improved 
diabetes and hypertension control for enrolled participants. 
• Activities: INSTEP’s pharmaco-economics research specialist will be evaluating 
data for A1c, blood pressure, and adherence for INSTEP participants and 
developing up models for cost savings for each participant where blood pressure 
or A1c was able to be lowered through improved adherence. Based on data, 
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simulation models of cost-benefit if INSTEP was scaled up to additional cities 
will be developed.  
5. By year 5, complete monitoring and evaluation of INSTEP to determine possibility for 
scaling up to additional locations. 
• Activities: INSTEPs public health specialist will establish both process and 
outcome measures for evaluating the program. Quality improvement initiatives 
will be carried out throughout the implementation of the project using PDSA 
cycles. Based on data gather during implementation in Umlazi, lessons learned 
will be used to create strategies to scale up the program. 
 
Program Implementation 
Implementation of INSTEP will occur in three phases, first with partnership 
development, second with a brief pilot program and then training and integration into primary 
health care workflow in all Umlazi clinics, and third with enrollment and data collection. All 
phases are in an effort to achieve the main goal of the program: to reduce complications from 
diabetes and hypertension by improving medication therapy adherence for patients in Umlazi 
township.  
 
Partnerships 
 Initiating and establishing all partners will occur through stakeholder meetings, either 
with individual organizations or as a large group. All stakeholder meetings will prioritize trust, 
transparency, and respect so that all those that are present feel comfortable speaking. 
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Establishing a partnership with an influential non-governmental organization in South 
Africa, Interactive Research and Development (IRD), and the Department of Health will be vital 
to the success of INSTEP. A stakeholder meeting will be called in the initial weeks to discuss the 
program concept and its implementation with key leaders in IRD to gain buy in. Stakeholders 
will have an opportunity to respond with their concerns, comments, and any requests for 
additions or changes to the program to more appropriately meet needs. The same process will be 
conducted with the Department of Health after support from IRB is obtained. Within the 
capabilities of the program and if requests are in line with 1) projected budget and 2) the ultimate 
goal of the program, changes or additions could be made to ensure stakeholders are accepting 
and in support of the program. Establishing a partnership with prominent local non-governmental 
organizations and the Department of Health will be the first action items for the program as it 
will aid in implementation of other aspects.  
 A separate stakeholder meeting will be held with key leaders at Prince Mshiyeni (after 
meeting with IRD and the Department of Health) to garner support for INSTEP. Points of 
emphasis during this meeting will be the support of the program from IRD and the Department 
of Health (presentation of relevant paperwork as proof), and the benefit to the patients and health 
care centers that will be enrolled in this program. An opportunity for hospital leadership to voice 
their concerns during this meeting will be provided and the program director will try to address 
all concerns or order to gain support from the Hospital. Additional stakeholder meetings on a 
quarterly basis to ensure stakeholder needs and concerns are being addressed. 
 Lastly, once partnerships are established with both the Department of Health, Prince 
Mshiyeni, and IRD, meetings with the director of each Primary Health Clinic in Umlazi will be 
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set to explain the program and the role of the clinic in enrolling participants and assisting with 
monthly or yearly monitoring of the patient.  
 
Training and Integration 
 An extensive training program will be developed and implemented at each Primary 
Health Clinic that agrees to be part of INSTEP. The training program will be repeated twice for 
each Clinic so that those who must work during the time of the training have an additional 
opportunity to attend. While all nurses and physicians are welcome to attend the training, the 
training will be required for nurses and physicians managing the chronic disease program at the 
primary health clinics. The training will consist of an introduction to INSTEP, a simulated 
training session showing the workflow of enrolling a patient into the INSTEP program, a 
practice component where nurses and physicians can get hands on opportunities to enroll their 
first patients under the guidance of program staff as well as use the A1c point of care machines 
and measure blood pressure, and will conclude with a question and answer session. Once trained, 
nurses and physicians will be asked to begin enrolling patients into the program and that INSTEP 
program staff would be occasionally stopping by to gather feedback on the patient enrollment 
process. Health care staff will be encouraged to enroll as many participants as possible into the 
program. 
 The trainings will occur first at nine prespecified Umlazi primary health clinics and those 
clinics will begin recruitment as a pilot program for a period of seven months. During this time, 
refinements will be made to the training program based on experiences in the nine clinics and 
training will be rolled out to the remaining clinics in Umlazi township. For the seven months, the 
program will run with a limited number of participants to determine opportunities for 
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improvement before expanding to all Umlazi clinics. Expanded recruitment of participants will 
begin upon completion of the seven month pilot program and any necessary adjustments have 
been made to INSTEP.  
 Nurses responsible for enrollment will be trained to complete three steps before the 
patient leaves the appointment. First, to ask the patient to sign an electronic consent form for the 
program, which will include a separate consent to provide a name and phone number to patients 
who may also live nearby to connect to social support. Second, the nurse will ask the patient to 
text “enroll” to a pre-specified clinic number, which will allow the program team to determine 
what patients are enrolling from which clinics. Third, the nurse will review with the patient when 
to take each of his/her medications so that the patient can correctly respond to the medication 
regimen questions being asked.  
 Nurses responsible for follow up of each of the participants will see them on a monthly 
basis per usual care. During each of these appointments, blood pressure will be taken, and the 
nurse will text the results to a prespecified number. Additionally, the nurse will ensure that the 
date of the next appointment is entered into the INSTEP system so that reminders for 
appointments can be made to the participant. 
 
Enrollment and Data Collection 
 INSTEP’s mHealth based program will be designed to assist the patient with adhering to 
medication therapy for diabetes and hypertension in three different ways: Reminders, Education, 
and Social Support. Messages will be sent to the patient through USSD and users will be able to 
interact by sending messages back. All information receive will be secured and only visible to 
	 38	
program team members. Enrolled members will be assigned a generated participant ID which 
will be provided for the participant in the event of a phone number change. 
Upon enrollment, participants will first) be asked if they have diabetes and/or 
hypertension, second) be asked how often they are scheduled to take their medications during the 
day for each disease state in order for the program to setup message reminders about daily 
medications, third) be asked a series of likert scale questions to better understand their current 
perceptions of self-efficacy, risk of complications due to diabetes and/or hypertension, and 
severity of complications due to diabetes and/or hypertension, fourth) when they prefer to 
receive educational related messages, and fifth) what area of Umlazi they live in. Message 
reminders for adherence will not include specific medication names, but will politely remind 
patients to take their diabetes or hypertension medications with a brief description of what the 
pill looks like (for easier identification by the patient). When received, patients will have the 
opportunity to message back (y) to confirm the medications have been taken or (n) to confirm 
that they were not able to be taken. A lack of response will be recorded as (n). Incentives to 
respond and be adherent to medications include a transportation voucher provided to the 
participant if he/she was 85% compliant to medications throughout the month, determined based 
on participant responses to adherence messages sent daily. Participants who are actively 
participating on a weekly basis in the program may also be eligible to receive travel vouchers if 
deemed necessary by the chronic disease nurses at the primary health clinics, but would be 
required to come to monthly clinic meetings to continue receiving the vouchers. Message 
reminders for appointments will also be sent two and one day before the appointment. In order to 
protect participant privacy in case a phone is misplaced or lost, participants who fail to interact 
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with the program after one week will be placed on hold until a message from the participant is 
received.  
In addition to the message reminders to take medications, messages regarding the risk of 
developing complications due to diabetes or hypertension, education about the disease state, and 
encouraging messages to improve compliance will also be sent, no more than once a day, at a 
pre-specified time that the patient requests. Educational messages will include named physicians 
from the primary health clinic. 
Lastly, when participants enroll into the program and indicate where they live, the 
participant will be informed that there are other program participants that live in nearby 
surrounding areas and if they would like to get in contact with them. If the participant indicates 
(y), contact information for two participants will be provided. Subsequent messages will 
encourage the participant to meet with the new contacts and solicit feedback on whether he/she 
did. 
Through messages a large amount of data will be collected. Information will be collected 
on participant demographics, adherence to medication therapy, HbA1c, blood pressure, and 
attendance at primary health care appointments. All data will be utilized to reach long-term goals 
of evaluating cost-benefit of the program over the five-year period. Additionally, through 
periodic visits (where interviews and brief focus groups will be conducted) to the primary 
healthcare clinics every six months, information on how the program is running, barriers that 
have been met, what is working well will be collected for continuous quality improvement 
opportunities and to aid the monitoring and evaluation process. 
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INPUT
S 
ACTIVITIES OUTPUTS SHORT TERM 
OUTCOMES 
IMPACT 
Human Resources: 
• Project Team 
• DoH personnel 
• Primary Health Care 
Clinic nurses and 
physicians 
 
Financial Resources: 
• Transportation 
vouchers provided 
through DoH 
• NIH R21: 
125,000/yearx2 
years 
• NIH R33: 
200,000/yearx3 
years 
 
Time: 
• Project Team: full 
time for 5 years 
 
Infrastructure: 
• Project Team work 
space 
 
Materials & Resources: 
• Computers & 
software 
• Office furniture and 
supplies 
• A1c Point of Care 
machines and test 
strips for clinics 
Automated blood 
pressure cuffs for clinics	
 
 
Developing partnership with 
Department of Health, 
Prince Mysheni, local non-
profits, and Primary Health 
Clinics 
 
Submit R21/R33 NIH Grant 
 
Recruitment of Program 
team 
 
Development of INSTEP 
mHealth USSD messaging 
system 
 
Training nurses and 
physicians to enroll 
participants 
 
Training nurses and 
physicians to use A1c point 
of care machines and blood 
pressure monitors 
 
Conducting visits to primary 
health clinics to interview 
individual nurses, 
physicians and patients 
 
Conducting visits to primary 
health clinics to conduct 
focus groups 
 
Evaluating data collected 
from messages. 
 
Developing process and 
outcome measures 
 
Conducting evaluations for 
quality improvement 
	
Partnerships with the 
Department of Health, 
Prince Mysheni, and 
Primary Health 
Clinics. 
 
Established program 
team 
 
INSTEP mHealth 
messaging program 
 
Enrollment of 
participants 
 
Trained nurses and 
physicians to 
implement INSTEP 
 
A1c and Blood 
pressure results of 
enrolled participants 
 
Feedback from nurses, 
physicians, and 
patients regarding 
INSTEP 
 
Data on medication 
adherence and clinic 
attendance 
 
Quality Improvement 
initiatives 
 
Cost-benefit analysis 
	
By month 3, establish a working 
partnership with IRD and the 
Department of Health 
 
By month 5, secure necessary funding 
for development and management of 
mHealth messaging technology and 
platform. 
 
By month 6, establish INSTEP’s 12-
member program team, including six 
local members from Umlazi. 
 
By month 6, establish a working 
relationship with the Primary Health 
Clinics in Umlazi Township. 
 
By month 8, develop mHealth 
messaging platform and have it ready 
for use. 
 
By month 12 conduct INSTEP 
trainings for all nurses and physicians 
in each of the Primary Health Clinics 
in Umlazi Township 
 
By month 13, ensure all primary 
health clinics in Umlazi are actively 
recruiting and participating in the 
INSTEP program. 
 
By month 18, enroll at least 200 
participants into the INSTEP program 
 
By month 24, increase self-efficacy 
and medication adherence of 
participants who have been enrolled 
in the program for at least 6 months 
by 15%. 
 
By month 24, have at least 50% of 
program participants meeting with a 
social support network of other 
patients with the same disease state. 
Reduced 
complications from 
uncontrolled diabetes 
and hypertension in 
Umlazi Township 
 
Increased sense of 
patient self-efficacy in 
being able to control 
their own chronic 
disease state 
 
Governmental cost-
savings in health care 
from prevented 
complications and 
hospital admissions 
 
Reduced morbidity 
and mortality in 
Umlazi township due 
to diabetes and 
hypertension 
	
By month 36, at least 
50% of all patients 
being seen at primary 
health clinics in Umlazi 
for diabetes or 
hypertension will be 
enrolled in INSTEP. 
 
By year 4, reduce A1c 
levels of at least 30% of 
INSTEP participants 
with diabetes by 3% or 
reach target goal of 
<7%. 
 
By year 4, reduce blood 
pressure of at least 30% 
of INSTEP participants 
with hypertension by 
20/10 mmHg or reach 
target goal of <130/80 
mm Hg for 3 or more 
months. 
 
By year 5, Complete 
cost-benefit evaluations 
to determine cost-
savings of improved 
diabetes and 
hypertension control 
for enrolled 
participants. 
 
By year 5, complete 
monitoring and 
evaluation of INSTEP 
to determine possibility 
for scaling up to 
additional locations. 
 
 
LONG TERM 
OUTCOMES 
Figure 3: INSTEP Logic Model 
Assumptions: Department of Health is in support of this program, NIH Grants are successfully awarded, messaging platform is technically feasible 
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Figure 4: GANTT Chart of INSTEP’s first two years 
	 42	
EVALUATION PLAN 
Rationale and Overview 
	 INSTEP is a multicomponent program and will require evaluation of both program 
implementation as well as program outcomes. Process evaluations will be necessary for both the 
training programs launched in the primary care centers to ensure that nurses and physicians 
understand the purpose of INSTEP, how it will run, and what they need to do for it to be 
successful, and for the running of the mHealth program with participants to ensure the program 
is being carried out with participants as planned. Outcome evaluations will be necessary to 
determine whether the combined interventions in the program are able to improve control and 
management of patients with diabetes and/or hypertension. Successful outcomes of the program 
will be vital to gain further support (both human and financial) from the Department of Health to 
scale the program to additional parts of the country. 
 Internal and external stakeholders will be involved in the evaluation process at different 
stages of the program. Within the training program portion of INSTEP, internal stakeholders will 
evaluate implementation and outcomes and external stakeholders will evaluate only 
implementation. Evaluation of the training program at the primary health care clinics will be 
essential in ensuring the training is appropriate to begin enrolled patients. Insufficient training of 
those directly involved in the program will result in poor implementation of the INSTEP 
program, impacting outcomes.  Internal evaluators will be necessary to ensure that the program is 
running as intended. External evaluators will be vital to continuous quality improvement 
measures and will evaluate implementation from a perspective of improvement, providing a 
strengths, weaknesses, opportunities, and threats (SWOT) analysis for each implementation 
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phase, based on their observations and data collected. The results of the implementation 
evaluation will provide much insight into opportunities to improve the INSTEP program. 
 The patient program, both implementation and outcomes, will be evaluated by external 
evaluators. External evaluators will be less likely to have bias in evaluating outcome results, 
providing a report on the true impact of the program. External evaluators will be from the South 
African Department of Health and partnering local non-profit non-governmental organizations. 
Results will inform on the true impact of the INSTEP program in improving the management of 
diabetes and hypertension. 
 
Potential Challenges 
	 INSTEP’s evaluation plan will be complex with two phases of implementation and 
outcomes evaluations. One major barrier will be ensuring that the evaluation remains within the 
estimated budget, as feedback for improvements from evaluations will inevitably require 
additional funds to ensure those aspects are addressed. The program team will have to ensure that 
limited resources are used to make the most impactful improvements to the program. 
 Due to the resource constrained settings of the primary health clinics, ensuring that the 
health care workforce at each clinic will have the time and resources needed to properly enroll 
and follow up with INSTEP participants will be difficult. In many of these settings, nurses are 
overworked and short on time, which could result in a rushed enrollment into the program where 
nurses have not collected or completed all the steps needed for the patient. Due to the many 
competing responsibilities they face in any given day and to ensure the nursing staff is receiving 
the appropriate support to fully carry out the duties in INSTEP, observations of their work will 
be made periodically to determine opportunities where support can be provided. It will be vital to 
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stress the importance of the enrollment and follow up process with the nurses during the training, 
and equally important to make sure that the enrollment process is as streamlined and quick as 
possible, taking no more than an additional 5-7 minutes. Nurses must feel comfortable and trust 
that by providing truthful answers, that the only outcome could be improvement or assistance 
rather than negative consequences.  
 An outcome evaluation challenge is the social support component of the program. 
INSTEP’s current mHealth program does not formally organize local gatherings for its 
participants, only putting them in touch with each other. It will be difficult to ensure impact of 
this portion of the program if participants are not acting on the contact information and meeting 
those in their local area for further support. To alleviate this potential barrier, overtime, the 
INSTEP program may identify highly compliant participants to serve as diabetes and 
hypertension champions that volunteer to be present on certain days at the primary health clinics 
to meet INSTEP participants and build supporting social relationships with them. This 
opportunity to recruit champions will occur overtime, and the initial champions can be recruited 
from the pilot program. Additionally, if the technology allows and if it is feasible, INSTEP may 
look into improving the program after launch and determining the possibility of providing meet-
up points and times within communities that participants reside in. Tackling this improvement 
would depend on the outcomes of this first phase of the program. 
 Barriers to patient adherence in low-socioeconomic areas often include losing their phone 
and acquiring a new number, or moving away from their current location, affecting the outcomes 
this program could have. Due to this, ensuring proper patient follow up may be challenging since 
INSTEP is based on mobile messaging to a registered number, and providing social support 
within the originally registered place of residence. The program will need to ensure there is an 
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easy way for participants to update their number and address while enrolled. To do so, at each 
primary health clinic visit with and enrolled participant, nurses in the program will be trained to 
ask about any changes in accommodation arrangements and text any changes in contact numbers 
or accommodation. They will also inform participants that they have the ability to text to update 
those changes if they want to. Although these updates will be in place, the program will 
anticipate to lose approximately 15% of its participants to loss to follow up. 
 Lastly, program evaluation, particularly for the outcomes of the program, exposes 
patients to a risk of breaching patient confidentiality. Evaluation will have to be completed very 
carefully without any patient identifiers to ensure privacy of patient data.	
 
Evaluation Design 
The evaluation will be completed using a mixed-methods approach, utilizing both 
quantitative and qualitative methods to gather implementation and outcomes data. Methods will 
be geared towards answering the following implementation and outcome questions (Table 3). 
Questions are categorized to either be quantitative or qualitative, evaluated by either an internal 
or external evaluators, and evaluating either the training portion of the program or the 
enrollment/patient portion of the program. Quantitative evaluations specify a unit of 
measurement that should be produced from that evaluation.  
The primary health care training program will be conducted by six members of the 
program team, of which three will be local to the town. Internal evaluators will be those who are 
not directly running the training program. Two internal evaluators will accompany the training 
team to each training session to record 1) time it takes to run the program, 2) whether trainers 
had all materials needed to run the training program, 3) number of nurse and physician attendees 
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(out of all of the nurses and physicians in the clinic), 4) if the training session was being 
conducted similar to ones given prior, and 5) any major barriers faced while implementing the 
training program. Additionally, these two evaluators will provide a training exit survey to 
physician and nurse participants that includes a demographic section (including first name and 
last name initial for tracking purposes), and questions that assess whether they feel comfortable 
implementing INSTEP after the training program and what feedback they may have about the 
training program. The two evaluators will also update the count on how many primary health 
clinics completed training for the week. Internal evaluators will remain consistent for the entire 
training program to ensure consistency in the evaluation methods. 
External evaluators will take on a relatively observational role in evaluating 
implementation of the training program. Two external evaluators, one from the Department of 
Health and one from a local non-profit, non-governmental organization partner, will attend at 
least two training sessions each week and observe the training program. They will be free to ask 
questions to trainers or participants as needed before or after the program, but will not interrupt 
the program while it is being given. They will also have access to data gathered by internal 
evaluators, as needed. Their goal will be to evaluate the implementation of the program to 
provide a SWOT analysis after the training programs have been provided for six weeks. 
External evaluators will be paired with at least one internal program team member and 
together, they will complete the implementation and outcome evaluation of the INSTEP program 
after the training and pilot program is completed. Six evaluators will be needed, three from the 
department of health, and three from a local non-profit, non-governmental organization partner. 
Evaluators will work in triplets consisting of one evaluator from each institution and an internal 
evaluator from the program team, and will be responsible for 1/3 of the primary health clinics in 
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Umlazi Township. To collect relevant qualitative data, evaluators will conduct survey 
evaluations at each of their assigned primary health care clinics at least once a month, surveying 
at least two nurses and two patients at each visit. The survey will include demographic data of 
the person completing the survey (first name + last name initial, role of either 
nurse/physician/patient, name of the primary health clinic), and questions on acceptability of the 
program and barriers faced. Questions will be formatted in both five-point Likert scale questions 
and open-ended questions that require written feedback. During the scheduled visits every two 
weeks, evaluators will also observe nurses enrolling patients into the program to gather data on 
the SWOT analysis and the quantitative analysis. 
Focus groups will be held with primary health clinics once every quarter and with patient 
participants within Umlazi township once every six months. Focus groups will inquire about 
topics similar to those asked in the evaluation surveys given every two weeks, but will allow 
deeper conversation among participants and the ability to further elaborate and ask follow up 
questions. In the primary health clinics, focus groups will be held separately with nurses and then 
physicians, to prevent any fear of sharing due to hierarchy. Focus groups with patients will be 
held within areas of Umlazi township that are accessible to participants. There will not be a set 
number of focus groups for patient participants as the requirement will be to hold sessions in as 
many areas as needed to capture at least feedback from 25% of the participants. Questions about 
how INSTEP has or hasn’t improved patient care, the acceptability of the program, barriers 
faced, and any feedback about the INSTEP program will be asked.  
Quantitative data needed to answer evaluation questions will be collected from the 
messaging database by the information technology specialist and provided to all of the evaluators 
on a monthly basis. Evaluators can ask for data at any point if it is necessary for their evaluation, 
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even if outside of the monthly report. Data will be provided on the following, which should 
provide sufficient data to answer the majority of quantitative implementation and outcome 
evaluation questions: 
• Number of patients enrolled each week at each primary health clinic 
• Total number of enrolled participants at time data was pulled, 
• Number of patients that have provided baseline HbA1c and blood pressure results 
• Current HbA1c and blood pressure results for each enrolled participant compared 
to baseline (if available) 
• Number of participants that have responded at least once to medication adherence 
messages vis the USSD messaging system. 
• Number of participants that have reported yes to meeting up with a social contact 
provided through INSTEP 
• Number of times participants have attended their clinic visit within a six-month 
period 
To assess for improvement in self-efficacy once every six-months, INSTEP will send 
questions on assess self-perceived self-efficacy through the USSD messaging system. All 
questions can be answered with a yes or no, and data will be provided to evaluators one month 
after the data is gathered. Lastly, evaluators will be allowed to ask questions of the program 
when as needed to assess progress in program implementation and any quality improvement 
initiatives that have been implemented. Using all of the data collected both quantitatively and 
qualitatively, a SWOT analysis of the program will be provided to the program team once every 
year for further quality improvement opportunities. 	
	 49	
Table 3: Evaluation Questions for INSTEP 
  
  
  
Implementation 
Questions Outcome Questions 
Training 
Program 
Internal 
Evaluator 
Quantitative 
How long, on average, 
does the training 
program take? (in hours) 
Have 100% of the primary 
health clinics in Umlazi 
township received at least 
two training sessions? 
(Yes/No) 
How many training 
sessions have trainers 
had insufficient 
resources to complete 
the training as planned 
(%) 
Have 100% of chronic 
disease nurses and 
physicians in Umlazi 
township primary health 
clinics completed a 
training session? (Yes/No) 
How many primary 
health clinics complete 
training each week? (#) 
What % of nurses report 
they feel comfortable 
implementing INSTEP 
after the training program 
(%) 
How many nurses and 
physicians are being 
trained each week? (#) 
What % of nurses report 
they want additional 
training or are 
uncomfortable 
implmenting the INSTEP 
program after completing 
the training program? (%) 
Qualitative 
What feedback do the 
nurses and physicians 
have about the training 
program?   
Is each training session 
being conducted in the 
same way?   
What major barriers 
have been faced in 
completing the training 
program for each 
primary health clinic?    
External 
Evaluator Qualitative 
What are the major 
strengths of the training 
program?   
What weaknesses are 
there to the training 
program?   
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Table 3: Evaluation Questions for INSTEP 
  
  
  
Implementation 
Questions Outcome Questions 
What opportunities are 
there for improving the 
training program?   
What threats are there to 
the training program?   
Patient 
Program 
External 
+ 
Internal 
Evaluator 
teams 
Quantitative 
How many patients are 
being enrolled each 
week? (#) 
By month 13, what % of 
primary health clinics are 
actively recruiting 
participants into the 
INSTEP program? (%) 
What % of nurses are 
following the complete 
enrollment protocol for 
patients enrolling into 
INSTEP? (%) 
Have at least 200 patients 
enrolled by month 18 of 
the program? (Yes/No) 
What % of enrolled 
patients are reporting 
their baseline HbA1c, 
blood pressure on 
enrollment? (%) 
At month 24, what % of 
enrolled participants in 
INSTEP for at least 6 
months reported improved 
self-efficacy in taking 
medications? (%) 
What percent of 
enrolled participants 
each month respond to 
medication adherence 
messages through the 
USSD messaging 
platform? (%) 
At month 24, what % of 
enrolled participants in 
INSTEP for at least 6 
months show data with 
improved medication 
adherence from baseline? 
(%) 
How many quality 
improvement initiatives 
are undertaken for the 
program each year? (#) 
By month 36, what % of 
patients being seen for 
chronic diseases at an 
Umlazi primary health 
clinic has enrolled into 
INSTEP? (%) 
What percent of 
participants report 
having met up with a 
social support contact 
provided through 
INSTEP? (%) 
By year 4, what % 
reduction, on average, in 
HbA1c is seen in enrolled 
INSTEP participants who 
have diabetes? (%) 
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Table 3: Evaluation Questions for INSTEP 
  
  
  
Implementation 
Questions Outcome Questions 
What % of participants 
have increased clinic 
attendance from 
baseline? (%) 
By year 4, what % of 
enrolled patients have 
reduced blood pressure by 
at least 20/10 mmgHg or 
reached a blood pressure 
goal of 130/80? (%) 
  
 
  
  
Qualitative 
How acceptable is 
INSTEP to patients, 
patient's families, nurses 
and physicians? 
Do patients, nurses, and 
physicians feel that being 
a part of INSTEP has 
improved patient care? 
What barriers have 
patients, nurses and 
physicians faced in 
being part of the 
INSTEP program? 
What feedback do 
patients, nurses, and 
physicians have about the 
INSTEP program? 
What are the major 
strengths of INSTEP?   
What weaknesses are 
there to INSTEP?   
What opportunities are 
there for improving 
INSTEP?   
What threats are there to 
the INSTEP?   
 
Institutional Review Board Considerations 
	 Due to the fact that patient identifiers and medication information will be collected 
during the implementation and evaluation portion of the program, it will be necessary for the 
program team to apply for Institutional Review Board approval if any of the data or if the 
program is going to be published through any avenue. To ensure this program abides by 
regulations for research in South Africa, the program team will apply for investigational review 
board approval at the start of the program, in which the submitted information will include a 
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copy of the consent form that participants will sign when they enroll into the program. The goal 
will be to get approval for the program prior to the enrollment of the first participant, which 
provides eight months for the program to acquire this approval. 
 
Dissemination Plan 
 INSTEP is planned to launch within Umlazi Township under the approval of the South 
Africa Department of Health. As the program will be enrolling participants through the primary 
health clinics, which are highly attended by many patients in the township, dissemination of the 
program will be mainly focused within the primary health clinics. Signs (in isiZulu) for the 
program will be posted within the patient rooms for chronic disease nurses and patient brochures 
in isiZulu and English will be provided to the nurses to give to patients. 	
 
CONCLUSION 
	 The diabetes and hypertension medication adherence program’s (INSTEP) ultimate aim 
is to reduce complications from diabetes and hypertension by improving medication therapy 
adherence for patients in Umlazi township. This program builds off knowledge gained through 
current literature and is developed to address two major NCD’s contributing to morbidity and 
mortality in South Africa. It combines three different strategies of improving diabetes and 
hypertension management through improving communication between health care workers, 
providing reminders for medication adherence, and providing an avenue for social support. The 
program’s technology is made to be accessible to those who may have limited access to airtime, 
breaking down a barrier to effective mHealth programs. 
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 Unique to any other publication about mHealth, the INSTEP program will undergo a 
cost-benefit analysis, conducted by a pharmaco-economics specialist, to evaluate the overall 
benefit of the program and estimated cost-savings. This data will be incredibly useful in better 
understanding the impact that INSTEP can have, and potentially create greater buy-in to expand 
the program to other areas of South Africa. Additionally, this will be the first mHealth based 
program that has partnered closely with the Department of Health, ensuring governmental 
support. 
 INSTEP is meant to be a sustainable program beyond the duration of grant funding. If 
cost-benefit analysis is positive, costs-savings could certainly outweigh the costs to maintain and 
scale up the program. Additional costs to continue the program and scale up would include 
training of additional health care workers in primary health clinics, a small monitoring and 
evaluation team, provision of travel vouchers, and maintaining the messaging platform. Overall, 
successful implementation of INSTEP could lead to the provision of a mHealth based program 
that serves as a tool for health care workers to prevent major complications of un-controlled 
diabetes and hypertension.  
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